☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
IASO Biotherapeutics
PharmaShots Weekly Snapshots (August 15 - 19, 2022)
August 19, 2022
IASO Biotherapeutics' Equecabtagene Autoleucel Receives the NMPA’s IND Approval for Neuromyelitis Optica Spectrum Disorder
August 19, 2022
IASO Biotherapeutics Reports the NMPA’s Acceptance of IND Application for Equecabtagene Autoleucel to Treat Neuromyelitis Optica S...
May 30, 2022
Load more...
Back to Home
